| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 4.9% | 2,422,600 | ORBIMED CAPITAL LLC | 31 Dec 2025 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2024 Q4 | 0 | $0 | -$9,560,857 | 0 | |
| 2024 Q3 | 1,075,105 | $9,557,683 | -$235,024,943 | $8.89 | 1 |
| 2024 Q2 | 288,773,149 | $78,245,741 | -$10,058,240 | $0.27 | 90 |
| 2024 Q1 | 315,135,502 | $130,233,863 | +$106,594,474 | $0.41 | 101 |
| 2023 Q4 | 57,206,011 | $23,451,165 | +$13,335,672 | $0.41 | 81 |
| 2023 Q3 | 23,314,978 | $12,387,898 | +$10,303,905 | $0.53 | 65 |
| 2023 Q2 | 4,005,533 | $1,514,135 | -$1,243,339 | $0.38 | 55 |
| 2023 Q1 | 7,323,756 | $2,821,544 | -$1,130,653 | $0.38 | 60 |
| 2022 Q4 | 11,316,981 | $3,414,299 | -$1,890,451 | $0.30 | 61 |
| 2022 Q3 | 16,842,748 | $8,172,904 | +$989,506 | $0.48 | 47 |
| 2022 Q2 | 14,570,683 | $8,147,690 | -$534,656 | $0.56 | 46 |
| 2022 Q1 | 15,082,373 | $12,325,043 | -$1,062,030 | $0.81 | 40 |
| 2021 Q4 | 16,384,695 | $19,469,480 | -$10,318,055 | $1.20 | 55 |
| 2021 Q3 | 23,660,893 | $51,874,776 | +$51,750,896 | $2.19 | 44 |
| 2021 Q2 | 57,800 | $117,000 | +$76,756 | $2.03 | 2 |
| 2021 Q1 | 20,000 | $20,000 | -$40,624,000 | $1.00 | 1 |
| 2020 Q4 | 27,278 | $40,644,000 | +$40,644,000 | $1489.99 | 1 |